WHAT IS THE FUTURE OF VALUE-BASED CARE?

Commercial risk will be a critical catalyst of progress – it’s complicated, but is it possible? We think so.

X

Research

The three payer trends that life sciences leaders need to know about in 2022

    As the health care ecosystem continues to evolve, life sciences leaders across both the pharmaceutical and medical device industries must understand how their customers’ priorities are changing—and what that means for their customer engagement, evidence generation, and communication strategies.

    In this series, we’re breaking down the top customer trends that life sciences leaders need to know about in 2022. To start, there are three key trends in the payer (health plan) space worth watching:

    1. Payers are increasingly turning to value-based contracts to prepare for the influx of ultra-high cost and novel drugs and to encourage appropriate device use, but have yet to expand the value framework for which they assess these new-in-kind products.
    2. Payers are reducing health care costs by steering patients to lower cost care pathways, treatment options, and sites of care.
    3. Despite promising innovations, payers are slow to cover precision diagnostic tools because they lack long-term outcomes and cost effectiveness data that demonstrate value and ROI.

    Read on to learn more about each trend and what it means for you.

      Not a member? Download a copy here.

    Other reports in this series

    This report is part of a series on the top customer trends that life sciences leaders need to know about in 2022. Check out the other customer trends:

    Hospitals/IDNs
    Independent physicians

    Log in to access this content

    Log in

    Don't have an account? Learn about membership benefits

    Have a Question?

    x

    Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.